Stocks
Funds
Screener
Sectors
Watchlists

Latest Madison Avenue Partners, LP Stock Portfolio

Madison Avenue Partners, LP Performance:
2025 Q3: 22.55%YTD: 28.29%2024: 16.45%

Performance for 2025 Q3 is 22.55%, and YTD is 28.29%, and 2024 is 16.45%.

About Madison Avenue Partners, LP and 13F Hedge Fund Stock Holdings

Madison Avenue Partners, LP is a hedge fund based in NEW YORK, NY. On 07-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $1.6 Billions. In it's latest 13F Holdings report, Madison Avenue Partners, LP reported an equity portfolio of $1.7 Billions as of 30 Sep, 2025.

The top stock holdings of Madison Avenue Partners, LP are GHC, , MKL. The fund has invested 17.3% of it's portfolio in GRAHAM HLDGS CO and 13.8% of portfolio in SANDISK CORP.

The fund managers got completely rid off SAGE THERAPEUTICS INC (SAGE), INNOVEX INTERNATIONAL INC and CANNAE HLDGS INC (CNNE) stocks. They significantly reduced their stock positions in NELNET INC (NNI), ALUMIS INC and WILEY JOHN & SONS INC (WLY). Madison Avenue Partners, LP opened new stock positions in BRITISH AMERN TOB PLC and NEWS CORP NEW (NWS). The fund showed a lot of confidence in some stocks as they added substantially to APARTMENT INVT & MGMT CO (AIV), GLOBUS MED INC (GMED) and GALAPAGOS NV.

Madison Avenue Partners, LP Annual Return Estimates Vs S&P 500

Our best estimate is that Madison Avenue Partners, LP made a return of 22.55% in the last quarter. In trailing 12 months, it's portfolio return was 29.52%.

New Buys

Ticker$ Bought
british amern tob plc64,957,600
news corp new44,631,500
centuri holdings inc14,673,700

New stocks bought by Madison Avenue Partners, LP

Additions


Additions to existing portfolio by Madison Avenue Partners, LP

Reductions

Ticker% Reduced
nelnet inc-78.13
alumis inc-77.32
wiley john & sons inc-42.97
sandisk corp-42.24
indivior plc-18.41
magnera corp-15.3
solventum corp-11.41

Madison Avenue Partners, LP reduced stake in above stock

Sold off

Ticker$ Sold
sage therapeutics inc-55,422,800
cargo therapeutics inc-17,277,700
pliant therapeutics inc-2,586,810
innovex international inc-27,616,100
ovid therapeutics inc-432,618
millrose pptys inc-23,543,700
cannae hldgs inc-14,058,100
arvinas inc-3,680,000

Madison Avenue Partners, LP got rid off the above stocks

Sector Distribution

Madison Avenue Partners, LP has about 43.2% of it's holdings in Others sector.

Sector%
Others43.2
Healthcare19.6
Consumer Defensive17.3
Financial Services9.9
Communication Services8.2
Real Estate2

Market Cap. Distribution

Madison Avenue Partners, LP has about 12.3% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
UNALLOCATED43.2
MID-CAP29
SMALL-CAP15.2
LARGE-CAP12.3

Stocks belong to which Index?

About 38.3% of the stocks held by Madison Avenue Partners, LP either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others61.8
RUSSELL 200035.6
S&P 5002.7
Top 5 Winners (%)%
sandisk corp
116.3 %
indivior plc
57.7 %
TBPH
theravance biopharma inc
32.4 %
STGW
stagwell inc
25.1 %
GHC
graham hldgs co
24.4 %
Top 5 Winners ($)$
sandisk corp
188.3 M
indivior plc
67.4 M
GHC
graham hldgs co
56.8 M
TBPH
theravance biopharma inc
34.0 M
galapagos nv
13.5 M
Top 5 Losers (%)%
WLY
wiley john & sons inc
-7.3 %
AIV
apartment invt & mgmt co
-6.0 %
MKL
markel group inc
-4.3 %
solventum corp
-3.5 %
magnera corp
-2.8 %
Top 5 Losers ($)$
MKL
markel group inc
-7.3 M
WLY
wiley john & sons inc
-6.7 M
solventum corp
-6.0 M
GMED
globus med inc
-3.7 M
AIV
apartment invt & mgmt co
-1.8 M

Madison Avenue Partners, LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Madison Avenue Partners, LP

Madison Avenue Partners, LP has 20 stocks in it's portfolio. About 86.9% of the portfolio is in top 10 stocks. MKL proved to be the most loss making stock for the portfolio. was the most profitable stock for Madison Avenue Partners, LP last quarter.

Last Reported on: 14 Nov, 2025
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions